High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
13 May 2024
Historique:
received: 08 02 2023
accepted: 25 03 2024
medline: 14 5 2024
pubmed: 14 5 2024
entrez: 13 5 2024
Statut: aheadofprint

Résumé

How human genetic variation contributes to vaccine effectiveness in infants is unclear, and data are limited on these relationships in populations with African ancestries. We undertook genetic analyses of vaccine antibody responses in infants from Uganda (n = 1391), Burkina Faso (n = 353) and South Africa (n = 755), identifying associations between human leukocyte antigen (HLA) and antibody response for five of eight tested antigens spanning pertussis, diphtheria and hepatitis B vaccines. In addition, through HLA typing 1,702 individuals from 11 populations of African ancestry derived predominantly from the 1000 Genomes Project, we constructed an imputation resource, fine-mapping class II HLA-DR and DQ associations explaining up to 10% of antibody response variance in our infant cohorts. We observed differences in the genetic architecture of pertussis antibody response between the cohorts with African ancestries and an independent cohort with European ancestry, but found no in silico evidence of differences in HLA peptide binding affinity or breadth. Using immune cell expression quantitative trait loci datasets derived from African-ancestry samples from the 1000 Genomes Project, we found evidence of differential HLA-DRB1 expression correlating with inferred protection from pertussis following vaccination. This work suggests that HLA-DRB1 expression may play a role in vaccine response and should be considered alongside peptide selection to improve vaccine design.

Identifiants

pubmed: 38740997
doi: 10.1038/s41591-024-02944-5
pii: 10.1038/s41591-024-02944-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Academy of Medical Sciences
ID : SGL024\1096
Pays : United Kingdom

Informations de copyright

© 2024. The Author(s).

Références

Ozawa, S. et al. Return on investment from childhood immunization in low- and middle-income countries, 2011–20. Health Aff. https://doi.org/10.1377/hlthaff.2015.1086 (2017).
Pollard, A. J. & Bijker, E. M. A guide to vaccinology: from basic principles to new developments. Nat. Rev. Immunol. 21, 83–100 (2020).
pubmed: 33353987 pmcid: 7754704 doi: 10.1038/s41577-020-00479-7
Cherry, J. D. Epidemic pertussis in 2012–the resurgence of a vaccine-preventable disease. N. Engl. J. Med. 367, 785–787 (2012).
pubmed: 22894554 doi: 10.1056/NEJMp1209051
Cherry, J. D. The 112-year odyssey of pertussis and pertussis vaccines–mistakes made and implications for the future. J. Pediatr. Infect. Dis. Soc. 8, 334–341 (2019).
doi: 10.1093/jpids/piz005
Schrager, L. K., Vekemens, J., Drager, N., Lewinsohn, D. M. & Olesen, O. F. The status of tuberculosis vaccine development. Lancet Infect. Dis. 20, e28–e37 (2020).
pubmed: 32014117 doi: 10.1016/S1473-3099(19)30625-5
Laurens, M. B. The promise of a malaria vaccine—are we closer? Annu. Rev. Microbiol. 72, 273–292 (2018).
pubmed: 30200856 doi: 10.1146/annurev-micro-090817-062427
Burton, D. R. Advancing an HIV vaccine; advancing vaccinology. Nat. Rev. Immunol. 19, 77–78 (2019).
pubmed: 30560910 pmcid: 6425752 doi: 10.1038/s41577-018-0103-6
Keehner, J. et al. Resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce. https://doi.org/10.1056/NEJMc2112981 (2021).
Plotkin, S. A. Correlates of protection induced by vaccination. Clin. Vaccin. Immunol. 17, 1055–1065 (2010).
doi: 10.1128/CVI.00131-10
Kwok, A. J., Mentzer, A. & Knight, J. C. Host genetics and infectious disease: new tools, insights and translational opportunities. Nat. Rev. Genet. 22, 137–153 (2020).
pubmed: 33277640 pmcid: 7716795 doi: 10.1038/s41576-020-00297-6
O’Connor, D. et al. Common genetic variations associated with the persistence of immunity following childhood immunization. Cell Rep. 27, 3241–3253 (2019).
pubmed: 31189108 doi: 10.1016/j.celrep.2019.05.053
Ovsyannikova, I. G. et al. A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses. PLoS ONE 12, e0171261 (2017).
pubmed: 28158231 pmcid: 5291460 doi: 10.1371/journal.pone.0171261
Trowsdale, J. & Knight, J. C. Major histocompatibility complex genomics and human disease. Annu Rev. Genomics Hum. Genet. 14, 301–323 (2013).
pubmed: 23875801 pmcid: 4426292 doi: 10.1146/annurev-genom-091212-153455
Chapman, S. J. & Hill, A. V. S. Human genetic susceptibility to infectious disease. Nat. Rev. Genet. 13, 175–188 (2012).
pubmed: 22310894 doi: 10.1038/nrg3114
Blackwell, J. M., Jamieson, S. E. & Burgner, D. HLA and infectious diseases. Clin. Microbiol. Rev. 22, 370–385 (2009).
pubmed: 19366919 pmcid: 2668228 doi: 10.1128/CMR.00048-08
Mentzer, A. J. et al. Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection. Nat. Med. https://doi.org/10.1038/S41591-022-02078-6 (2022).
doi: 10.1038/S41591-022-02078-6 pubmed: 36228659 pmcid: 9873562
Moutsianas, L. et al. Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat. Genet. 47, 1107–1113 (2015).
Goyette, P. et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat. Genet. 47, 172–179 (2015).
pubmed: 25559196 pmcid: 4310771 doi: 10.1038/ng.3176
Ramsuran, V. et al. Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells. Science https://doi.org/10.1126/science.aam8825 (2018).
doi: 10.1126/science.aam8825 pubmed: 29302013 pmcid: 5933048
Gurdasani, D. et al. Uganda genome resource enables insights into population history and genomic discovery in Africa. Cell 179, 984–1002 (2019).
pubmed: 31675503 pmcid: 7202134 doi: 10.1016/j.cell.2019.10.004
Dilthey, A. et al. Multi-population classical HLA type imputation. PLoS Comput. Biol. 9, e1002877 (2013).
pubmed: 23459081 pmcid: 3572961 doi: 10.1371/journal.pcbi.1002877
Luo, Y. et al. A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response. Nat. Genet. 53, 1504–1516 (2021).
pubmed: 34611364 pmcid: 8959399 doi: 10.1038/s41588-021-00935-7
McMahon, G., Ring, S. M., Davey-Smith, G. & Timpson, N. J. Genome-wide association study identifies SNPs in the MHC class II loci that are associated with self-reported history of whooping cough. Hum. Mol. Genet. 24, 5930–5939 (2015).
pubmed: 26231221 pmcid: 4581602 doi: 10.1093/hmg/ddv293
Dan, J. M. et al. A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4
pubmed: 27342848 doi: 10.4049/jimmunol.1600318
Schmiedel, B. J. et al. Impact of genetic polymorphisms on human immune cell gene expression. Cell 175, 1701–1715 (2018).
pubmed: 30449622 pmcid: 6289654 doi: 10.1016/j.cell.2018.10.022
Orrù, V. et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat. Genet. 52, 1036–1045 (2020).
pubmed: 32929287 pmcid: 8517961
Zhang, Z. et al. Host genetic determinants of hepatitis B virus infection. Front. Genet. 10, 696 (2019).
pubmed: 31475028 pmcid: 6702792 doi: 10.3389/fgene.2019.00696
Akcay, I. M., Katrinli, S., Ozdil, K., Doganay, G. D. & Doganay, L. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J. Gastroenterol. 24, 3347–3360 (2018).
pubmed: 30122875 pmcid: 6092584 doi: 10.3748/wjg.v24.i30.3347
Haralambieva, I. H. et al. Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine. Hum. Genet 136, 421–435 (2017).
pubmed: 28289848 pmcid: 5433429 doi: 10.1007/s00439-017-1768-9
Prentice, H. A. et al. HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition. Sci. Transl. Med. 7, 296ra112 (2015).
pubmed: 26180102 pmcid: 4911012 doi: 10.1126/scitranslmed.aab4005
Sveinbjornsson, G. et al. HLA class II sequence variants influence tuberculosis risk in populations of European ancestry. Nat. Genet. 48, 318–322 (2016).
pubmed: 26829749 pmcid: 5081101 doi: 10.1038/ng.3498
Kamatani, Y. et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 41, 591–595 (2009).
pubmed: 19349983 doi: 10.1038/ng.348
Nishida, N. et al. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS ONE 7, e39175 (2012).
pubmed: 22737229 pmcid: 3380898 doi: 10.1371/journal.pone.0039175
Low, J. S. et al. Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. Science 372, 1336–1341 (2021).
pubmed: 34006597 doi: 10.1126/science.abg8985
Vince, N. et al. HLA-C level is regulated by a polymorphic Oct1 binding site in the HLA-C promoter region. Am. J. Hum. Genet. 99, 1353–1358 (2016).
pubmed: 27817866 pmcid: 5142108 doi: 10.1016/j.ajhg.2016.09.023
Gutierrez-Arcelus, M. et al. Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci. Nat. Genet. 52, 247–253 (2020).
pubmed: 32066938 pmcid: 7135372 doi: 10.1038/s41588-020-0579-4
Moore, S. E. et al. Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan. Trop. Med. Int. Health 11, 1529–1541 (2006).
pubmed: 17002727 doi: 10.1111/j.1365-3156.2006.01700.x
Fang, J. W. S., Lai, C. L., Chung, H. T., Wu, P. C. & Lau, J. Y. N. Female children respond to recombinant hepatitis b vaccine with a higher titre than male. J. Trop. Pediatr. 40, 104–107 (1994).
pubmed: 8015023 doi: 10.1093/tropej/40.2.104
Kooijman, S. et al. Novel identified aluminum hydroxide-induced pathways prove monocyte activation and pro-inflammatory preparedness. J. Proteom. 175, 144–155 (2018).
doi: 10.1016/j.jprot.2017.12.021
Becker, R. A. & Wilks, A. R. Maps in S. AT&T Bell Laboratories Statistics Research Report [93.2] http://ect.bell-labs.com/sl/doc/93.2.ps (1993).
International HapMap 3 Consortium et al. Integrating common and rare genetic variation in diverse human populations. Nature 467, 52–58 (2010).
Webb, E. L. et al. Effect of single-dose anthelmintic treatment during pregnancy on an infant’s response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial. Lancet 377, 52–62 (2011).
pubmed: 21176950 pmcid: 3018567 doi: 10.1016/S0140-6736(10)61457-2
Nash, S. et al. The impact of prenatal exposure to parasitic infections and to anthelminthic treatment on antibody responses to routine immunisations given in infancy: secondary analysis of a randomised controlled trial. PLoS Negl. Trop. Dis. 11, e0005213 (2017).
pubmed: 28178298 pmcid: 5298230 doi: 10.1371/journal.pntd.0005213
Nunes, M. C. et al. Duration of infant protection against influenza illness conferred by maternal immunization: secondary analysis of a randomized clinical trial. JAMA Pediatr. 170, 840–847 (2016).
pubmed: 27380464 doi: 10.1001/jamapediatrics.2016.0921
Madhi, S. A. et al. Influenza vaccination of pregnant women and protection of their infants. N. Engl. J. Med. 371, 918–931 (2014).
pubmed: 25184864 doi: 10.1056/NEJMoa1401480
Bliss, C. M. et al. Viral vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants. Mol. Ther. 25, 547–559 (2017).
pubmed: 28153101 pmcid: 5368405 doi: 10.1016/j.ymthe.2016.11.003
Tiono, A. B. et al. First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5–17 months old infants and children. PLoS ONE 13, e0208328 (2018).
pubmed: 30540808 pmcid: 6291132 doi: 10.1371/journal.pone.0208328
Boyd, A. et al. Cohort profile: the ‘children of the 90s’—The index offspring of the Avon Longitudinal Study of Parents and Children. Int. J. Epidemiol. 42, 111–127 (2013).
pubmed: 22507743 doi: 10.1093/ije/dys064
Fraser, A. et al. Cohort profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int. J. Epidemiol. 42, 97–110 (2013).
pubmed: 22507742 doi: 10.1093/ije/dys066
Cereb, N., Kim, H. R., Ryu, J. & Yang, S. Y. Advances in DNA sequencing technologies for high resolution HLA typing. Hum. Immunol. 76, 923–927 (2015).
pubmed: 26423536 doi: 10.1016/j.humimm.2015.09.015
Mack, S. J. et al. Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens 81, 194–203 (2013).
pubmed: 23510415 pmcid: 3634360 doi: 10.1111/tan.12093
Gourraud, P. A. et al. HLA diversity in the 1000 genomes dataset. PLoS ONE 9, e97282 (2014).
pubmed: 24988075 pmcid: 4079705 doi: 10.1371/journal.pone.0097282
Smits, G. P., van Gageldonk, P. G., Schouls, L. M., van der Klis, F. R. & Berbers, G. A. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin. Vaccine Immunol. 19, 396–400 (2012).
pubmed: 22237896 pmcid: 3294611 doi: 10.1128/CVI.05537-11
van Gageldonk, P. G., van Schaijk, F. G., van der Klis, F. R. & Berbers, G. A. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J. Immunol. Methods 335, 79–89 (2008).
pubmed: 18407287 doi: 10.1016/j.jim.2008.02.018
de Voer, R. M., Schepp, R. M., Versteegh, F. G., van der Klis, F. R. & Berbers, G. A. Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay. Clin. Vaccin. Immunol. 16, 433–436 (2009).
doi: 10.1128/CVI.00364-08
Swart, E. M. et al. Long-term protection against diphtheria in the Netherlands after 50 years of vaccination: results from a seroepidemiological study. PLoS ONE 11, e0148605 (2016).
pubmed: 26863307 pmcid: 4749226 doi: 10.1371/journal.pone.0148605
Brinkman, I. D. et al. Early measles vaccination during an outbreak in the Netherlands: reduced short and long-term antibody responses in children vaccinated before 12 months of age. J. Infect. Dis. https://doi.org/10.1093/infdis/jiz159 (2019).
Bancroft, T. et al. Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood. Cell Immunol. 304–305, 35–43 (2016).
pubmed: 27212461 pmcid: 4899275 doi: 10.1016/j.cellimm.2016.05.002
Lindestam Arlehamn, C. S. et al. Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3
pubmed: 23358848 pmcid: 3554618 doi: 10.1371/journal.ppat.1003130
Weiskopf, D. et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8
pubmed: 23580623 pmcid: 3670335 doi: 10.1073/pnas.1305227110
Frazier, A. et al. Allergy-associated T cell epitope repertoires are surprisingly diverse and include non-IgE reactive antigens. World Allergy Organ. J. 7, 26 (2014).
pubmed: 25352946 pmcid: 4210551 doi: 10.1186/1939-4551-7-26
Schmiedel, B. J. et al. Impact of genetic polymorphisms on human immune cell gene expression resource impact of genetic polymorphisms on human immune cell gene expression. Cell 175, 1701–1715 (2018).
pubmed: 30449622 pmcid: 6289654 doi: 10.1016/j.cell.2018.10.022
Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).
pubmed: 17194218 pmcid: 1713260 doi: 10.1371/journal.pgen.0020190
Gurdasani, D. et al. The African Genome Variation Project shapes medical genetics in Africa. Nature https://doi.org/10.1038/nature13997 (2015).
doi: 10.1038/nature13997 pubmed: 25470054
Delaneau, O., Marchini, J. & Zagury, J. F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179–181 (2011).
pubmed: 22138821 doi: 10.1038/nmeth.1785
Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955–959 (2012).
pubmed: 22820512 pmcid: 3696580 doi: 10.1038/ng.2354
Keenan, K., McGinnity, P., Cross, T. F., Crozier, W. W. & Prodohl, P. A. DiveRsity: an R package for the estimation and exploration of population genetics parameters and their associated errors. Methods Ecol. Evol. 4, 782–788 (2013).
doi: 10.1111/2041-210X.12067
Henn, B. M. et al. Hunter-gatherer genomic diversity suggests a southern African origin for modern humans. Proc. Natl Acad. Sci. USA 108, 5154–5162 (2011).
pubmed: 21383195 pmcid: 3069156 doi: 10.1073/pnas.1017511108
Pirinen, M., Donnelly, P. & Spencer, C. C. Including known covariates can reduce power to detect genetic effects in case–control studies. Nat. Genet. 44, 848–851 (2012).
pubmed: 22820511 doi: 10.1038/ng.2346
Yang, J., Zaitlen, N. A., Goddard, M. E., Visscher, P. M. & Price, A. L. Advantages and pitfalls in the application of mixed-model association methods. Nat. Genet. https://doi.org/10.1038/ng.2876 (2014).
doi: 10.1038/ng.2876 pubmed: 25420146 pmcid: 4250049
Zhou, X. & Stephens, M. Efficient multivariate linear mixed model algorithms for genome-wide association studies. Nat. Methods 11, 407–409 (2014).
pubmed: 24531419 pmcid: 4211878 doi: 10.1038/nmeth.2848
Han, B. & Eskin, E. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am. J. Hum. Genet. 88, 586–598 (2011).
pubmed: 21565292 pmcid: 3146723 doi: 10.1016/j.ajhg.2011.04.014
Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 8, e64683 (2013).
pubmed: 23762245 pmcid: 3675122 doi: 10.1371/journal.pone.0064683
Zheng, X. et al. HIBAG–HLA genotype imputation with attribute bagging. Pharmacogenomics J. 14, 192–200 (2014).
pubmed: 23712092 doi: 10.1038/tpj.2013.18
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353–1358 (2012).
pubmed: 22492648 pmcid: 3348564 doi: 10.1093/bioinformatics/bts163
Aguiar, V. R. C., César, J., Delaneau, O., Dermitzakis, E. T. & Meyer, D. Expression estimation and eQTL mapping for HLA genes with a personalized pipeline. PLoS Genet. 15, e1008091 (2019).
pubmed: 31009447 pmcid: 6497317 doi: 10.1371/journal.pgen.1008091
Vita, R. et al. The Immune Epitope Database (IEDB) 3.0. Nucleic Acids Res. 43, D405–D412 (2015).
pubmed: 25300482 doi: 10.1093/nar/gku938
Wang, P. et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11, 568 (2010).
pubmed: 21092157 pmcid: 2998531 doi: 10.1186/1471-2105-11-568
Mentzer, A. et al. High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response: summary statistics (1.0.0). Zenodo https://doi.org/10.5281/zenodo.7357687 (2022).
Mentzer, A. High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response: script for testing amino-acid correlation (1.0.0).Zenodo https://doi.org/10.5281/zenodo.10728920 (2024).
doi: 10.5281/zenodo.10728920

Auteurs

Alexander J Mentzer (AJ)

Centre for Human Genetics, University of Oxford, Oxford, UK. alexander.mentzer@ndm.ox.ac.uk.
Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK. alexander.mentzer@ndm.ox.ac.uk.

Alexander T Dilthey (AT)

Centre for Human Genetics, University of Oxford, Oxford, UK.
Institute of Medical Microbiology and Hospital Hygiene, University Hospital of Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.

Martin Pollard (M)

Wellcome Sanger Institute, Cambridge, UK.

Deepti Gurdasani (D)

Wellcome Sanger Institute, Cambridge, UK.

Emre Karakoc (E)

Wellcome Sanger Institute, Cambridge, UK.

Tommy Carstensen (T)

Wellcome Sanger Institute, Cambridge, UK.

Allan Muhwezi (A)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.

Clare Cutland (C)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Amidou Diarra (A)

Groupe de Recherche Action en Santé (GRAS) 06 BP 10248, Ouagadougou, Burkina Faso.

Ricardo da Silva Antunes (R)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Sinu Paul (S)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Gaby Smits (G)

National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Susan Wareing (S)

Microbiology Department, John Radcliffe Hospital, Oxford University NHS Foundation Trust, Oxford, UK.

HwaRan Kim (H)

Histogenetics, New York, USA.

Cristina Pomilla (C)

Wellcome Sanger Institute, Cambridge, UK.

Amanda Y Chong (AY)

Centre for Human Genetics, University of Oxford, Oxford, UK.

Debora Y C Brandt (DYC)

Department of Integrative Biology, University of California at Berkeley, California, CA, USA.

Rasmus Nielsen (R)

Department of Integrative Biology, University of California at Berkeley, California, CA, USA.

Samuel Neaves (S)

Avon Longitudinal Study of Parents and Children at University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Nicolas Timpson (N)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Austin Crinklaw (A)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Cecilia S Lindestam Arlehamn (CS)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Anna Rautanen (A)

Centre for Human Genetics, University of Oxford, Oxford, UK.

Dennison Kizito (D)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.

Tom Parks (T)

Centre for Human Genetics, University of Oxford, Oxford, UK.
Department of Infectious Disease, Imperial College London, London, UK.

Kathryn Auckland (K)

Centre for Human Genetics, University of Oxford, Oxford, UK.

Kate E Elliott (KE)

Centre for Human Genetics, University of Oxford, Oxford, UK.

Tara Mills (T)

Centre for Human Genetics, University of Oxford, Oxford, UK.

Katie Ewer (K)

The Jenner Institute, University of Oxford, Oxford, UK.

Nick Edwards (N)

The Jenner Institute, University of Oxford, Oxford, UK.

Segun Fatumo (S)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
The Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine London, London, UK.

Emily Webb (E)

MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine London, London, UK.

Sarah Peacock (S)

Tissue Typing Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Katie Jeffery (K)

Microbiology Department, John Radcliffe Hospital, Oxford University NHS Foundation Trust, Oxford, UK.
Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Fiona R M van der Klis (FRM)

National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Pontiano Kaleebu (P)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.

Pandurangan Vijayanand (P)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Bjorn Peters (B)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Department of Medicine, University of California, San Diego, La Jolla, CA, USA.

Alessandro Sette (A)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Department of Medicine, University of California, San Diego, La Jolla, CA, USA.

Nezih Cereb (N)

Histogenetics, New York, USA.

Sodiomon Sirima (S)

Groupe de Recherche Action en Santé (GRAS) 06 BP 10248, Ouagadougou, Burkina Faso.

Shabir A Madhi (SA)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Alison M Elliott (AM)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine London, London, UK.

Gil McVean (G)

Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.

Adrian V S Hill (AVS)

Centre for Human Genetics, University of Oxford, Oxford, UK.
The Jenner Institute, University of Oxford, Oxford, UK.

Manjinder S Sandhu (MS)

Department of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK. m.sandhu@imperial.ac.uk.

Classifications MeSH